This week on Lunch Money, Leighton Roberts (Sharesies' Co-Founder) and Alice Rountree (Sharesies' Financial Analyst) catch up with David Darling, the CEO of Pacific Edge.  Pacific Edge is a Dunedin-based company that’s listed on the NZX, and specialises in developing cancer diagnostic tests. David talks us through the fascinating history of this life saving company, an overview of products and the markets they operate in and what is the future for David now he's stepping away from the company after 20 years.  If you have any questions, email us at any time at [email protected]. If there are any companies, fund managers, or other special guests you’d like to see on Lunch Money going forward, flick us an email at [email protected] to let us know! For more market news, subscribe to our Lunch Money market updates—bite-sized emails on the New Zealand, Australian, and US share markets and the wider economy, written by Sharesies’ Lead Dealer, Sophie Goodwin: https://www.sharesies.nz/lunch-moneySee omnystudio.com/listener for privacy information.

Ver todos los episodios